Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Novastan

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Thrombolytic therapy has become a standard treatment for selected patients with acute myocardial infarction (MI). Various… Expand
  • figure 1
2002
2002
The minimal cost algorithm (MCA) commonly used for quantitative coronary arteriography has limitations in definition of complex… Expand
Review
2000
Review
2000
Unfractionated heparin has enjoyed the sole anticoagulant status for almost half a century. Besides an effective anticoagulant… Expand
Highly Cited
1999
Highly Cited
1999
OBJECTIVES This study examined the effect of a small-molecule, direct thrombin inhibitor, argatroban, on reperfusion induced by… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Highly Cited
1999
Highly Cited
1999
A multicenter clinical trial of the thrombin inhibitor argatroban (Novastan; Texas Biotechnology, Houston, TX; Smith-Kline… Expand
Highly Cited
1999
Highly Cited
1999
Despite the use of potent anticoagulants such as r-hirudin and argatroban, the morbidity/mortality of heparin-induced… Expand
Review
1998
Review
1998
From injury through healing, thrombin has several important functions in blood clotting, subsequent clot lysis, and tissue repair… Expand
Review
1997
Review
1997
Because of the unsatisfactory options available for safe and effective antithrombotic therapy, recent, intense research and… Expand
Review
1997
Review
1997
Heparin-induced thrombocytopenia (HIT) is a syndrome that has been identified with increased frequency. The mortality associated… Expand
1997
1997
We describe a case of a 70-year-old male who underwent coronary artery bypass surgery which was complicated by multiple… Expand